“showed a trend”

NonHRT‐women had significantly higher TPR ( F (1, 105) = 6.10, r = 0.24, p = 0.015) and showed a trend towards lower SV ( F (1, 105) = 3.14, r = 0.02, p = 0.079) compared to men.

The experimental group showed a trend toward a higher pCR rate ( P =0.079).

Indeed, positive patients for anti-CL IgG/IgM showed a trend to have lower platelet levels than negative patients (209.8 ± 69.3 × 10 3 / μ L versus 241.1 ± 69.6 × 10 3 / μ L, P = 0.079, resp.). 4.

Male sex showed a trend ( P = 0.079) toward protection for venous events (HR = 0.49; 95%CI, 0.22–1.09) (Table 5 ).

Interestingly, when toripalimab was administrated two days after chemotherapy rather than being used simultaneously, the combinational neoadjuvant regime showed a trend toward a higher pCR rate (36.4%, 4/11 versus 7.7%, 1/13, P = 0.079) ( 60 ).

Although not statistically significant, neonates born via caesarean section showed a trend toward delayed oxygenation compared with those delivered vaginally, with mean pre-ductal times of 9.05 vs. 8.41 minutes, respectively (p = 0.079).

Participants in the 600 mg and 900 mg NMN-treated group walked a significantly longer distance at both 30-day and 60-day compared to baseline (all p < 0.05), while the 300 mg NMN group showed a trend at day 60 ( p = 0.079).

Although low FT4 levels showed a trend toward increased obesity risk (OR = 2.46; 95% CI, 0.90–6.81; p = 0.079), this association did not reach statistical significance after adjustment (Supplementary Table 3).

In the PA.7 trial involving patients with metastatic pancreatic adenocarcinoma, individuals with CH treated with immune checkpoint inhibitors showed a trend toward improved progression-free survival (PFS) (HR=0.55; 95% CI: 0.28–1.07; P =0.079).

Although not reaching statistical significance, NLR and RDW showed a trend toward higher values in patients with excess weight ( p = 0.079 and p = 0.076, respectively).

In HIs group, the heterozygous genotype of SNPs (rs3831958, rs1052230 and rs1052231) showed a trend of downregulated CD3ζ protein level compared with dominant genotype (p = 0.079).

Karyotypic analysis revealed a higher proportion of poor karyotypes in the multiple mutation subgroup ( p = 0.046), while cytogenetic risk stratification showed a trend toward more very poor risk in the multiple mutation group ( p = 0.079).

Increasing age showed a trend toward a lower hazard of reinjection (HR per year 0.99, 95% CI 0.98 to 1.00; p = 0.079).

Among short-chain fatty acids, hexanoic acid (C6) showed a trend toward higher levels in sarcopenic patients ( p = 0.079).

Our enhanced Model 3 demonstrated exceptional predictive performance (AUC 0.929), statistically comparable to SOFA ( p = 0.052), and showed a trend toward superiority over APACHE II (AUC 0.900, p = 0.079).

Condition showed a trend to significance ( β = 2.03, SE = 1.15, t = 1.77, p = .079, CI [−.24, 4.29]) on positive attitudes toward gay people.

The BAT positive participants were significantly younger ( p = 0.046), showed a trend toward having a lower systolic blood pressure ( p = 0.079), but were not significantly different in body surface area (BSA), BMI, waist circumference, percent body fat, fat free mass, diastolic blood pressure, or fasting blood glucose ( p ≥ 0.177) when compared to participants who did not achieve sufficient levels of cold-induced BAT activation (SUV max < 1.5 g/mL; BAT negative ) ( Table 1 ). 3.3.

Long-term incubation with COVID19 patient serum also had effects on cellular arrhythmogenic potential: Ca 2+ waves showed a trend to occur more often upon incubation with patient serum as compared to control (0.22 ± 0.04 vs 0.37 ± 0.04 (control vs patient), waves/sec, n = 32 vs 49, p = 0.079) and spontaneous Ca 2+ release events (i.e.

MutSigs 2 showed a trend to enriched in active immune subgroup (Chi-square, 57.5%, P = 0.079), while MutSigs 13 exhibited a trend to enriched in exhausted subgroup (Chi-square, 34.8%, P = 0.130) (Fig. 3 d).

In addition, we also noticed that RALGPS1 showed a trend of down-regulation in SCZ cases compared with controls ( P = 0.079).

Progression for PRAGMA-CF subscores were found: square root of %Bronchiectasis showed a trend towards progression by 0.139 (p = 0.079) ( Fig 4A ).

In our previous study we showed a trend for improved OS for average risk patients treated with chemotherapy after a median follow up of 10 years ( p = 0.079) [ 15 ] .

8g,h,k,l ), while p-Speed putative PV-expressing CA3 interneurons showed a trend of prospective speed representation ( t -test, P = 0.079, Fig. 8g , Supplementary Table S5 ).

The K-M survival analysis revealed that patients with high NOK expression (median survival time: 12.0 months) showed a trend of shorter OS than those of low NOK expression (median survival time: 19.5 months, P= 0.0790; Supplementary Figure 1 ), which was consistent with our previous study. 12 The association between NOK expression and the clinicopathological variables was analyzed ( Table 1 ).

0.155–0.988), whilst presence of cirrhosis just showed a trend at multivariate analysis, without reaching the statistical significance (p = 0.079; O.R.: 0.153; 95% C.I. 0.019–1.239) (Table 3 ).